Ebola: Working Toward Treatments and Vaccines.
نویسندگان
چکیده
After killing more than 11,000 people in West Africa, the largest known outbreak of the deadly Ebola virus has largely subsided-but development of effective antiviral countermeasures remains a concern. Several experimental products show promise.
منابع مشابه
Ethical considerations of experimental interventions in the Ebola outbreak.
Background The outbreak of Ebola virus raging in west Africa is special in two respects. First, with more than 2100 infections and 1100 deaths, it has already become the most severe and largest documented Ebola outbreak. It is also occurring in some of the world’s least developed countries, and is therefore extremely complex to address. Second, experimental interventions that are still in the p...
متن کاملConsiderations in the Use of Nonhuman Primate Models of Ebola Virus and Marburg Virus Infection.
The filoviruses, Ebola virus and Marburg virus, are zoonotic pathogens that cause severe hemorrhagic fever in humans and nonhuman primates (NHPs), with case-fatality rates ranging from 23% to 90%. The current outbreak of Ebola virus infection in West Africa, with >26 000 cases, demonstrates the long-underestimated public health danger that filoviruses pose as natural human pathogens. Currently,...
متن کاملEmergency treatment for exposure to Ebola virus: the need to fast-track promising vaccines.
Ebola virus is among the most deadly pathogens, with case fatality rates of up to 90%.1 Ebola virus is categorized as a tier 1 pathogen by the US government because of its potential for deliberate misuse with significant potential for mass casualties. The current outbreak of Ebola virus in West Africawithmore than23 000casesand9000deaths2alsodemonstrates the long-underestimated public health th...
متن کاملDrug targets in infections with Ebola and Marburg viruses.
The development of antiviral drugs for Ebola and Marburg viruses has been slow. To date, beyond supportive care, no effective treatments, prophylactic measures, therapies, or vaccines are approved to treat or prevent filovirus infections. In this review, we examine the current treatments available to administer care for filovirus infection, the potential therapeutic targets that can be used for...
متن کاملThe Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG).
Recombinant viral vectors provide an effective means for heterologous antigen expression in vivo and thus represent promising platforms for developing novel vaccines against human pathogens from Ebola to tuberculosis. An increasing number of candidate viral vector vaccines are entering human clinical trials. The Brighton Collaboration Viral Vector Vaccines Safety Working Group (V3SWG) was forme...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
- P & T : a peer-reviewed journal for formulary management
دوره 40 8 شماره
صفحات -
تاریخ انتشار 2015